Menu
GeneBe

2-218823787-G-A

Variant summary

Our verdict is Benign. Variant got -14 ACMG points: 0P and 14B. BP4_StrongBP6_ModerateBS1BS2

The NM_017431.4(PRKAG3):c.1445C>T(p.Ala482Val) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.00121 in 1,614,120 control chromosomes in the GnomAD database, including 18 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★). Another nucleotide change resulting in same amino acid change has been previously reported as Likely benignin UniProt.

Frequency

Genomes: 𝑓 0.0057 ( 6 hom., cov: 32)
Exomes 𝑓: 0.00074 ( 12 hom. )

Consequence

PRKAG3
NM_017431.4 missense

Scores

4
6
5

Clinical Significance

Benign criteria provided, single submitter B:1

Conservation

PhyloP100: 7.28
Variant links:
Genes affected
PRKAG3 (HGNC:9387): (protein kinase AMP-activated non-catalytic subunit gamma 3) The protein encoded by this gene is a regulatory subunit of the AMP-activated protein kinase (AMPK). AMPK is a heterotrimer consisting of an alpha catalytic subunit, and non-catalytic beta and gamma subunits. AMPK is an important energy-sensing enzyme that monitors cellular energy status. In response to cellular metabolic stresses, AMPK is activated, and thus phosphorylates and inactivates acetyl-CoA carboxylase (ACC) and beta-hydroxy beta-methylglutaryl-CoA reductase (HMGCR), key enzymes involved in regulating de novo biosynthesis of fatty acid and cholesterol. This subunit is one of the gamma regulatory subunits of AMPK. It is dominantly expressed in skeletal muscle. Studies of the pig counterpart suggest that this subunit may play a key role in the regulation of energy metabolism in skeletal muscle. [provided by RefSeq, Jul 2008]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -14 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.009650469).
BP6
Variant 2-218823787-G-A is Benign according to our data. Variant chr2-218823787-G-A is described in ClinVar as [Benign]. Clinvar id is 3041896.Status of the report is criteria_provided_single_submitter, 1 stars.
BS1
Variant frequency is greater than expected in population afr. gnomad4 allele frequency = 0.00574 (874/152324) while in subpopulation AFR AF= 0.0196 (814/41552). AF 95% confidence interval is 0.0185. There are 6 homozygotes in gnomad4. There are 447 alleles in male gnomad4 subpopulation. Median coverage is 32. This position pass quality control queck.
BS2
High AC in GnomAd at 869 AD gene.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE UniProt
PRKAG3NM_017431.4 linkuse as main transcriptc.1445C>T p.Ala482Val missense_variant 13/14 ENST00000439262.7

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Appris UniProt
PRKAG3ENST00000439262.7 linkuse as main transcriptc.1445C>T p.Ala482Val missense_variant 13/141 NM_017431.4 P1Q9UGI9-1
PRKAG3ENST00000529249.5 linkuse as main transcriptc.1445C>T p.Ala482Val missense_variant 13/131 P1Q9UGI9-1

Frequencies

GnomAD3 genomes
AF:
0.00571
AC:
869
AN:
152206
Hom.:
6
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0196
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00255
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.000103
Gnomad OTH
AF:
0.00621
GnomAD3 exomes
AF:
0.00164
AC:
412
AN:
251346
Hom.:
3
AF XY:
0.00119
AC XY:
161
AN XY:
135856
show subpopulations
Gnomad AFR exome
AF:
0.0223
Gnomad AMR exome
AF:
0.000781
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad SAS exome
AF:
0.0000327
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.000106
Gnomad OTH exome
AF:
0.00147
GnomAD4 exome
AF:
0.000737
AC:
1077
AN:
1461796
Hom.:
12
Cov.:
31
AF XY:
0.000660
AC XY:
480
AN XY:
727200
show subpopulations
Gnomad4 AFR exome
AF:
0.0238
Gnomad4 AMR exome
AF:
0.000917
Gnomad4 ASJ exome
AF:
0.0000383
Gnomad4 EAS exome
AF:
0.00
Gnomad4 SAS exome
AF:
0.0000464
Gnomad4 FIN exome
AF:
0.00
Gnomad4 NFE exome
AF:
0.0000962
Gnomad4 OTH exome
AF:
0.00177
GnomAD4 genome
AF:
0.00574
AC:
874
AN:
152324
Hom.:
6
Cov.:
32
AF XY:
0.00600
AC XY:
447
AN XY:
74490
show subpopulations
Gnomad4 AFR
AF:
0.0196
Gnomad4 AMR
AF:
0.00255
Gnomad4 ASJ
AF:
0.00
Gnomad4 EAS
AF:
0.00
Gnomad4 SAS
AF:
0.00
Gnomad4 FIN
AF:
0.00
Gnomad4 NFE
AF:
0.000103
Gnomad4 OTH
AF:
0.00662
Alfa
AF:
0.00120
Hom.:
2
Bravo
AF:
0.00629
ESP6500AA
AF:
0.0175
AC:
77
ESP6500EA
AF:
0.00
AC:
0
ExAC
AF:
0.00192
AC:
233
Asia WGS
AF:
0.00115
AC:
4
AN:
3478
EpiCase
AF:
0.000109
EpiControl
AF:
0.000237

ClinVar

Significance: Benign
Submissions summary: Benign:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

PRKAG3-related disorder Benign:1
Benign, criteria provided, single submitterclinical testingPreventionGenetics, part of Exact SciencesNov 25, 2019This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.29
BayesDel_addAF
Benign
-0.20
T
BayesDel_noAF
Uncertain
-0.040
Cadd
Uncertain
25
Dann
Pathogenic
1.0
DEOGEN2
Benign
0.34
T;T
Eigen
Pathogenic
0.80
Eigen_PC
Pathogenic
0.74
FATHMM_MKL
Uncertain
0.92
D
LIST_S2
Uncertain
0.93
D;.
MetaRNN
Benign
0.0097
T;T
MetaSVM
Uncertain
0.36
D
MutationTaster
Benign
1.0
D;D;D
PrimateAI
Uncertain
0.63
T
REVEL
Pathogenic
0.65
Sift4G
Uncertain
0.0050
D;D
Polyphen
1.0
D;D
Vest4
0.43
MVP
0.95
MPC
0.34
ClinPred
0.025
T
GERP RS
5.2
Varity_R
0.34
gMVP
0.79

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs34720726; hg19: chr2-219688510; API